> Investors > SEC Filings

SEC Filings

Form 10-Q
ACETO CORP filed this Form 10-Q on 02/03/2017
Document Outline
Entire Document (1853.3 KB)
Subdocument 1 - 10-Q - FORM 10-Q
Page 1 - For the quarterly period ended December 31, 2016
Page 2 - ACETO CORPORATION AND SUBSIDIARIES
Page 3 - PART I. FINANCIAL INFORMATION
Page 4 - ACETO CORPORATION AND SUBSIDIARIES
Page 5 - ACETO CORPORATION AND SUBSIDIARIES
Page 6 - ACETO CORPORATION AND SUBSIDIARIES
Page 7 - ACETO CORPORATION AND SUBSIDIARIES
Page 8 - ACETO CORPORATION AND SUBSIDIARIES
Page 9 - ACETO CORPORATION AND SUBSIDIARIES
Page 10 - ACETO CORPORATION AND SUBSIDIARIES
Page 11 - ACETO CORPORATION AND SUBSIDIARIES
Page 12 - ACETO CORPORATION AND SUBSIDIARIES
Page 13 - ACETO CORPORATION AND SUBSIDIARIES
Page 14 - ACETO CORPORATION AND SUBSIDIARIES
Page 15 - ACETO CORPORATION AND SUBSIDIARIES
Page 16 - ACETO CORPORATION AND SUBSIDIARIES
Page 17 - ACETO CORPORATION AND SUBSIDIARIES
Page 18 - ACETO CORPORATION AND SUBSIDIARIES
Page 19 - ACETO CORPORATION AND SUBSIDIARIES
Page 20 - ACETO CORPORATION AND SUBSIDIARIES
Page 21 - ACETO CORPORATION AND SUBSIDIARIES
Page 22 - Report of Independent Registered Public Accounting Firm
Page 23 - Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Page 24 - Medicines Use and Spending in the U.S.: A Review of 2015 and Outlook to 2020
Page 25 - Outlook for Global Medicines Through 2021: Balancing Cost and Value
Page 26 - N/A
Page 27 - Six Months Ended December 31, 2016 Compared to Six Months Ended December 31, 2015
Page 28 - Pharmaceutical Ingredients
Page 29 - Selling, General and Administrative Expenses
Page 30 - Three Months Ended December 31, 2016 Compared to Three Months Ended December 31, 2015
Page 31 - Pharmaceutical Ingredients
Page 32 - Selling, General and Administrative Expenses
Page 33 - Credit Facilities
Page 34 - Working Capital Outlook
Page 35 - Impact of Recent Accounting Pronouncements
Page 36 - Income Taxes (Topic 740) Balance Sheet Classification of Deferred Assets.
Page 37 - Foreign Currency Exchange Risk
Page 38 - PART II. OTHER INFORMATION
Page 39 - N/A
Page 40 - N/A
Subdocument 2 - EX-3.1 - EXHIBIT 3.1
Page 1 - Exhibit 3.1
Page 2 - N/A
Page 3 - provided, however
Page 4 - N/A
Page 5 - N/A
Page 6 - provided
Page 7 - IN WITNESS WHEREOF
Subdocument 3 - EX-3.2 - EXHIBIT 3.2
Page 1 - Exhibit 3.2
Page 2 - N/A
Subdocument 4 - EX-3.3 - EXHIBIT 3.3
Page 1 - Exhibit 3.3
Page 2 - N/A
Subdocument 5 - EX-15.1 - EXHIBIT 15.1
Page 1 - Exhibit 15.1
Subdocument 6 - EX-31.1 - EXHIBIT 31.1
Page 1 - Exhibit 31.1
Subdocument 7 - EX-31.2 - EXHIBIT 31.2
Page 1 - Exhibit 31.2
Subdocument 8 - EX-32.1 - EXHIBIT 32.1
Page 1 - Exhibit 32.1
Subdocument 9 - EX-32.2 - EXHIBIT 32.2
Page 1 - Exhibit 32.2
XBRL Item - EX-101.INS - XBRL INSTANCE DOCUMENT (What's this?)
XBRL Item - EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA (What's this?)
XBRL Item - EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE (What's this?)
XBRL Item - EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE (What's this?)
XBRL Item - EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE (What's this?)
XBRL Item - EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE (What's this?)
XBRL Viewer

top